Biotechnology & Life Sciences Global On demand · 24-48h

Global Biotechnology Market Strategic Research Report

$3,500 USD

Strategic Research Report

Global Biotechnology Market

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: DNA Sequencing, Nanobiotechnology, Tissue Engineering & Regeneration, PCR Technology, Fermentation, Chromatography, Gene Amplification Technologies, Synthetic Biology, CRISPR & Gene-Editing Tools, Biochips & Microarrays, Others

By Application: Health & Red Biotechnology, Food & Agriculture (Green), Industrial Processing (White), Environmental & Natural Resources (Grey), Bioinformatics & Omics, Others

Key Players: Amgen Inc., Biogen Inc., Gilead Sciences Inc., Illumina Inc., Thermo Fisher Scientific Inc., Regeneron Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Vertex Pharmaceuticals Inc., CSL Ltd., Lonza Group AG, Novozymes A/S, Catalent Inc., Charles River Laboratories International Inc., Genmab A/S, CRISPR Therapeutics AG, Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Bluebird Bio Inc., Gingko Bioworks Holdings Inc., Zymergen Inc., Twist Bioscience Corp.

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2024 · forecast to 2032

Length: 150 pages

Overview

Scope of the Report

Covering the period 2026 to 2032, this report looks at the global Biotechnology market from the viewpoint of the companies that supply it, the customers that buy from it and the investors that follow it.

The scope is global, with separate views of product type, end application, five regions and 27 countries so that readers can focus on the parts of the market that matter to them.

Market Segmentation

The report breaks the Biotechnology market down as follows, and each segment is sized and forecast to 2032:

By Technology: DNA Sequencing, Nanobiotechnology, Tissue Engineering & Regeneration, PCR Technology, Fermentation, Chromatography, Gene Amplification Technologies, Synthetic Biology, CRISPR & Gene-Editing Tools, Biochips & Microarrays and Others
By Application: Health & Red Biotechnology, Food & Agriculture (Green), Industrial Processing (White), Environmental & Natural Resources (Grey), Bioinformatics & Omics and Others
By End User: Biopharma & Biotechnology Companies, CMOs & CROs, Academic & Research Institutes, Hospitals & Diagnostic Centres, Agricultural Corporations and Environmental Agencies & NGOs
By Product Type: Biopharmaceuticals, Bioprocess Equipment & Consumables, Reagents & Kits, Bioservices, Bioinformatics Platforms & Software and Others

Regional analysis covers Asia Pacific, North America, Europe, the Middle East and Africa and Latin America, with country-level forecasts.

Market Context

Biotechnology and life sciences markets tend to be shaped by research funding, scientific advances, regulatory pathways and the pace of translation from lab to clinic. In a market such as Biotechnology, competition typically depends on product or service quality, price positioning, distribution reach and the ability to meet evolving customer requirements.

Competitive Landscape

The competitive analysis profiles 25 companies active in the Biotechnology market: Amgen Inc., Biogen Inc., Gilead Sciences Inc., Illumina Inc., Thermo Fisher Scientific Inc., Regeneron Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Vertex Pharmaceuticals Inc., CSL Ltd., Lonza Group AG, Novozymes A/S, Catalent Inc., Charles River Laboratories International Inc., Genmab A/S, CRISPR Therapeutics AG, Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Bluebird Bio Inc., Gingko Bioworks Holdings Inc., Zymergen Inc. and Twist Bioscience Corp..

Each profile reviews the company's overview, key products and segments, financial performance, business strategy and SWOT, with strategic implications for 2026 to 2032.

What the Report Covers

Its chapters cover:

How the Biotechnology market is defined, how large it is and how it is forecast to grow from 2026 to 2032
Segmentation of Biotechnology by product type and end application, with a growth outlook for each
Regional outlook for five regions and country-level forecasts for 27 countries
Growth drivers and inhibitors, with an assessment of how strongly each affects the outlook
Profiles of key companies, competitive positioning and the strategic moves shaping rivalry in Biotechnology
Structural analysis using the Porter's Five Forces, PESTLE and SWOT frameworks
Future trends, technology and innovation, and the investment and M&A outlook

The report is produced on demand to the scope described here and delivered in PDF within 24 to 48 hours of purchase.

Key Questions Answered

How large is the global Biotechnology market today, and how is it expected to grow between 2026 and 2032?
What is driving demand for Biotechnology, and what could slow growth?
How does the Biotechnology market differ by end user (Biopharma & Biotechnology Companies, CMOs & CROs and Academic & Research Institutes)?
How does the Biotechnology market differ by product type (Biopharmaceuticals, Bioprocess Equipment & Consumables and Reagents & Kits)?
How do Amgen Inc., Biogen Inc. and Gilead Sciences Inc. and the other profiled companies compare on positioning and strategy in Biotechnology?
Which technology and innovation trends are most likely to change the Biotechnology market?

Who Can Use This Report

Companies active in Biotechnology benchmarking their position and planning product, capacity and go-to-market strategy
Customers, distributors and channel partners such as Health & Red Biotechnology, Food & Agriculture (Green) and Industrial Processing (White) evaluating demand and sourcing options
Investment professionals, advisers and strategy teams looking for a structured view of opportunity and risk
Associations, public bodies and academic or research teams following sector developments

Segments covered in this report

By Type

DNA SequencingNanobiotechnologyTissue Engineering & RegenerationPCR TechnologyFermentationChromatographyGene Amplification TechnologiesSynthetic BiologyCRISPR & Gene-Editing ToolsBiochips & MicroarraysOthers

By Application

Health & Red BiotechnologyFood & Agriculture (Green)Industrial Processing (White)Environmental & Natural Resources (Grey)Bioinformatics & OmicsOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Segment Outlook by Technology
2.1.4 Segment Outlook by Application
2.1.5 Segment Outlook by End User
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Technology

3.1 Market Segmentation by Technology
3.1.1 Market by Technology Overview
3.1.2 DNA Sequencing
3.1.3 Nanobiotechnology
3.1.4 Tissue Engineering & Regeneration
3.1.5 PCR Technology
3.1.6 Fermentation
3.1.7 Chromatography
3.1.8 Gene Amplification Technologies
3.1.9 Synthetic Biology
3.1.10 CRISPR & Gene-Editing Tools
3.1.11 Biochips & Microarrays
3.1.12 Others

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Health & Red Biotechnology
4.1.3 Food & Agriculture (Green)
4.1.4 Industrial Processing (White)
4.1.5 Environmental & Natural Resources (Grey)
4.1.6 Bioinformatics & Omics
4.1.7 Others

05Market Segmentation by End User

5.1 Market Segmentation by End User
5.1.1 Market by End User Overview
5.1.2 Biopharma & Biotechnology Companies
5.1.3 CMOs & CROs
5.1.4 Academic & Research Institutes
5.1.5 Hospitals & Diagnostic Centres
5.1.6 Agricultural Corporations
5.1.7 Environmental Agencies & NGOs

06Market Segmentation by Product Type

6.1 Market Segmentation by Product Type
6.1.1 Market by Product Type Overview
6.1.2 Biopharmaceuticals
6.1.3 Bioprocess Equipment & Consumables
6.1.4 Reagents & Kits
6.1.5 Bioservices
6.1.6 Bioinformatics Platforms & Software
6.1.7 Others

07Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

08Country-Level Market Forecast

8.1 Asia Pacific
8.1.1 China
8.1.2 Japan
8.1.3 India
8.1.4 Australia
8.1.5 South Korea
8.1.6 Rest of Asia Pacific
8.2 North America
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.2.4 Rest of North America
8.3 Europe
8.3.1 Germany
8.3.2 United Kingdom
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Middle East & Africa
8.4.1 Israel
8.4.2 Saudi Arabia
8.4.3 United Arab Emirates
8.4.4 Turkey
8.4.5 South Africa
8.4.6 Egypt
8.4.7 Nigeria
8.4.8 Rest of Middle East & Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America

09Growth Drivers & Inhibitors

9.1 Growth Drivers & Inhibitors
9.1.1 Section Overview
9.1.2 Growth Drivers
9.1.3 Growth Inhibitors
9.1.4 Driver and Inhibitor Impact Assessment
9.1.5 Analyst Perspective

10Key Company Profiles

10.1 Amgen Inc.
10.1.1 Company Overview
10.1.2 Key Products & Segments
10.1.3 Financial Performance (2023–2025)
10.1.4 Business Strategy
10.1.5 SWOT Analysis
10.1.6 Strategic Implications (2026–2032)
10.2 Biogen Inc.
10.2.1 Company Overview
10.2.2 Key Products & Segments
10.2.3 Financial Performance (2023–2025)
10.2.4 Business Strategy
10.2.5 SWOT Analysis
10.2.6 Strategic Implications (2026–2032)
10.3 Gilead Sciences Inc.
10.3.1 Company Overview
10.3.2 Key Products & Segments
10.3.3 Financial Performance (2023–2025)
10.3.4 Business Strategy
10.3.5 SWOT Analysis
10.3.6 Strategic Implications (2026–2032)
10.4 Illumina Inc.
10.4.1 Company Overview
10.4.2 Key Products & Segments
10.4.3 Financial Performance (2023–2025)
10.4.4 Business Strategy
10.4.5 SWOT Analysis
10.4.6 Strategic Implications (2026–2032)
10.5 Thermo Fisher Scientific Inc.
10.5.1 Company Overview
10.5.2 Key Products & Segments
10.5.3 Financial Performance (2023–2025)
10.5.4 Business Strategy
10.5.5 SWOT Analysis
10.5.6 Strategic Implications (2026–2032)
10.6 Regeneron Pharmaceuticals Inc.
10.6.1 Company Overview
10.6.2 Key Products & Segments
10.6.3 Financial Performance (2023–2025)
10.6.4 Business Strategy
10.6.5 SWOT Analysis
10.6.6 Strategic Implications (2026–2032)
10.7 Moderna Inc.
10.7.1 Company Overview
10.7.2 Key Products & Segments
10.7.3 Financial Performance (2023–2025)
10.7.4 Business Strategy
10.7.5 SWOT Analysis
10.7.6 Strategic Implications (2026–2032)
10.8 BioNTech SE
10.8.1 Company Overview
10.8.2 Key Products & Segments
10.8.3 Financial Performance (2023–2025)
10.8.4 Business Strategy
10.8.5 SWOT Analysis
10.8.6 Strategic Implications (2026–2032)
10.9 Vertex Pharmaceuticals Inc.
10.9.1 Company Overview
10.9.2 Key Products & Segments
10.9.3 Financial Performance (2023–2025)
10.9.4 Business Strategy
10.9.5 SWOT Analysis
10.9.6 Strategic Implications (2026–2032)
10.10 CSL Ltd.
10.10.1 Company Overview
10.10.2 Key Products & Segments
10.10.3 Financial Performance (2023–2025)
10.10.4 Business Strategy
10.10.5 SWOT Analysis
10.10.6 Strategic Implications (2026–2032)
10.11 Lonza Group AG
10.11.1 Company Overview
10.11.2 Key Products & Segments
10.11.3 Financial Performance (2023–2025)
10.11.4 Business Strategy
10.11.5 SWOT Analysis
10.11.6 Strategic Implications (2026–2032)
10.12 Novozymes A/S
10.12.1 Company Overview
10.12.2 Key Products & Segments
10.12.3 Financial Performance (2023–2025)
10.12.4 Business Strategy
10.12.5 SWOT Analysis
10.12.6 Strategic Implications (2026–2032)
10.13 Catalent Inc.
10.13.1 Company Overview
10.13.2 Key Products & Segments
10.13.3 Financial Performance (2023–2025)
10.13.4 Business Strategy
10.13.5 SWOT Analysis
10.13.6 Strategic Implications (2026–2032)
10.14 Charles River Laboratories International Inc.
10.14.1 Company Overview
10.14.2 Key Products & Segments
10.14.3 Financial Performance (2023–2025)
10.14.4 Business Strategy
10.14.5 SWOT Analysis
10.14.6 Strategic Implications (2026–2032)
10.15 Genmab A/S
10.15.1 Company Overview
10.15.2 Key Products & Segments
10.15.3 Financial Performance (2023–2025)
10.15.4 Business Strategy
10.15.5 SWOT Analysis
10.15.6 Strategic Implications (2026–2032)
10.16 CRISPR Therapeutics AG
10.16.1 Company Overview
10.16.2 Key Products & Segments
10.16.3 Financial Performance (2023–2025)
10.16.4 Business Strategy
10.16.5 SWOT Analysis
10.16.6 Strategic Implications (2026–2032)
10.17 Editas Medicine Inc.
10.17.1 Company Overview
10.17.2 Key Products & Segments
10.17.3 Financial Performance (2023–2025)
10.17.4 Business Strategy
10.17.5 SWOT Analysis
10.17.6 Strategic Implications (2026–2032)
10.18 Intellia Therapeutics Inc.
10.18.1 Company Overview
10.18.2 Key Products & Segments
10.18.3 Financial Performance (2023–2025)
10.18.4 Business Strategy
10.18.5 SWOT Analysis
10.18.6 Strategic Implications (2026–2032)
10.19 Sangamo Therapeutics Inc.
10.19.1 Company Overview
10.19.2 Key Products & Segments
10.19.3 Financial Performance (2023–2025)
10.19.4 Business Strategy
10.19.5 SWOT Analysis
10.19.6 Strategic Implications (2026–2032)
10.20 Alnylam Pharmaceuticals Inc.
10.20.1 Company Overview
10.20.2 Key Products & Segments
10.20.3 Financial Performance (2023–2025)
10.20.4 Business Strategy
10.20.5 SWOT Analysis
10.20.6 Strategic Implications (2026–2032)
10.21 Sarepta Therapeutics Inc.
10.21.1 Company Overview
10.21.2 Key Products & Segments
10.21.3 Financial Performance (2023–2025)
10.21.4 Business Strategy
10.21.5 SWOT Analysis
10.21.6 Strategic Implications (2026–2032)
10.22 Bluebird Bio Inc.
10.22.1 Company Overview
10.22.2 Key Products & Segments
10.22.3 Financial Performance (2023–2025)
10.22.4 Business Strategy
10.22.5 SWOT Analysis
10.22.6 Strategic Implications (2026–2032)
10.23 Gingko Bioworks Holdings Inc.
10.23.1 Company Overview
10.23.2 Key Products & Segments
10.23.3 Financial Performance (2023–2025)
10.23.4 Business Strategy
10.23.5 SWOT Analysis
10.23.6 Strategic Implications (2026–2032)
10.24 Zymergen Inc.
10.24.1 Company Overview
10.24.2 Key Products & Segments
10.24.3 Financial Performance (2023–2025)
10.24.4 Business Strategy
10.24.5 SWOT Analysis
10.24.6 Strategic Implications (2026–2032)
10.25 Twist Bioscience Corp.
10.25.1 Company Overview
10.25.2 Key Products & Segments
10.25.3 Financial Performance (2023–2025)
10.25.4 Business Strategy
10.25.5 SWOT Analysis
10.25.6 Strategic Implications (2026–2032)

11Competitive Landscape

11.1 Competitive Landscape Overview
11.2 Competitive Intensity Assessment
11.3 Key Player Strategies & Positioning
11.4 Competitive Dynamics & Strategic Outlook
11.4.1 Emerging Competitive Threats
11.4.2 Consolidation vs. Fragmentation Outlook
11.4.3 Competitive Response Matrix
11.4.4 Strategic Recommendations, 2026–2032

12Porter's Five Forces Analysis

12.1 Threat of New Entrants
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Threat of Substitutes
12.5 Competitive Rivalry

13PESTLE Analysis

13.1 Political
13.2 Economic
13.3 Social and Demographic
13.4 Technological
13.5 Legal and Regulatory
13.6 Environmental
13.7 Strategic Implications of the PESTLE Assessment

14SWOT Analysis

15Future Trends & Outlook

15.1 Future Trends & Outlook
15.1.1 Trend Summary and Commercial Maturity Assessment
15.1.2 Technology and Innovation Trends
15.1.3 Long-Term Market Outlook
15.1.4 Investment & M&A Activity Outlook
15.1.5 Overall Outlook Assessment

Frequently asked questions

Which regions and countries are covered for Biotechnology?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 27 country-level markets including China, Japan, United States, Canada, Germany, United Kingdom, Israel and Saudi Arabia.

How is the Biotechnology market segmented?

The market is segmented by Technology (DNA Sequencing, Nanobiotechnology, Tissue Engineering & Regeneration, PCR Technology, Fermentation, Chromatography and 5 more), Application (Health & Red Biotechnology, Food & Agriculture (Green), Industrial Processing (White), Environmental & Natural Resources (Grey), Bioinformatics & Omics and Others), End User (Biopharma & Biotechnology Companies, CMOs & CROs, Academic & Research Institutes, Hospitals & Diagnostic Centres, Agricultural Corporations and Environmental Agencies & NGOs) and Product Type (Biopharmaceuticals, Bioprocess Equipment & Consumables, Reagents & Kits, Bioservices, Bioinformatics Platforms & Software and Others), with forecasts for each segment.

Who are the key players in the Biotechnology market?

Key players profiled include Amgen, Biogen, Gilead Sciences, Illumina, Thermo Fisher Scientific, Regeneron Pharmaceuticals, Moderna, BioNTech SE, Vertex Pharmaceuticals, CSL and 15 more, among 25 companies covered in total.

Who should buy the Biotechnology market report?

The report is intended for manufacturers and solution providers, distributors and end users, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biotechnology market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license

from $3,500.00

Optional add-ons

Word Document (DOCX) +$500 PowerPoint Slides +$500 Excel Data Sheet +$500 Language Translation +$750

On demand · delivered within 24-48 hours

Secure checkout · SSL encrypted

License terms included

Post-purchase analyst support

Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →

Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600

Global Biotechnology Market Strategic Research Report

Overview

Scope of the Report

Market Segmentation

Market Context

Competitive Landscape

What the Report Covers

Key Questions Answered

Who Can Use This Report

Segments covered in this report

Table of contents

Frequently asked questions

Research Methodology

Need a customized version?

Leading Brands in This Industry

Global Biotechnology Market Strategic Research Report

Overview

Scope of the Report

Market Segmentation

Market Context

Competitive Landscape

What the Report Covers

Key Questions Answered

Who Can Use This Report

Segments covered in this report

Table of contents

Frequently asked questions

Research Methodology

Related reports

Global Point-of-Care CRISPR Diagnostic Kit Market Strategic Research Report

Global Single-Use Bioreactor Consumables Assembly Market Strategic Research Report

Global Magnetic Bead Nucleic Acid Extraction Kit Market Strategic Research Report

Need a customized version?

Leading Brands in This Industry